05:41 PM EDT, 07/19/2024 (MT Newswires) -- Peter Salzmann, Director, Chief Executive Officer, on July 17, 2024, sold 8,685 shares in Immunovant ( IMVT ) for $257,888. Following the Form 4 filing with the SEC, Salzmann has control over a total of 1,023,412 shares of the company, with 1,023,412 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1764013/000176401324000133/xslF345X03/wk-form4_1721424975.xml

Price: 28.00, Change: +0.03, Percent Change: +0.11